ロード中...
Omalizumab decreases IgE production in patients with allergic (IgE-mediated) asthma; PKPD analysis of a biomarker, total IgE
AIM: To determine whether excessive IgE production by patients with atopic allergic asthma decreases with omalizumab therapy. METHODS: Omalizumab, free and total IgE data were obtained from an epidemiological study and six randomized, double-blind, placebo-controlled trials in patients with allergic...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Science Inc
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3162660/ https://ncbi.nlm.nih.gov/pubmed/21392073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2011.03962.x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|